LRMR · Larimar Therapeutics, Inc.
$3.93
+0.10 (+2.61%)
At close · Jul 21
Market Cap
$408.26M
Shares
103.88M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-29 | — | |
| 8-K | 2026-05-19 | — | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K | 2026-05-14 | — | |
| DEF 14A | 2026-04-20 | 2026-04-17 | |
| 10-K | 2026-03-19 | 2025-12-31 | |
| 8-K | 2026-03-19 | — | |
| 8-K | 2026-03-09 | — | |
| 8-K | 2026-02-27 | 2026-02-25 | |
| 8-K | 2026-02-24 | — | |
| 8-K | 2026-01-22 | 2026-01-21 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-17 | 2025-12-16 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 8-K | 2025-10-14 | — | |
| 8-K | 2025-09-29 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-14 | — | |
| 8-K | 2025-07-31 | 2025-07-29 | |
| 8-K | 2025-07-29 | — | |
| 8-K | 2025-06-23 | — | |
| 8-K | 2025-06-23 | — | |
| 8-K | 2025-05-13 | — | |
| 8-K | 2025-05-05 | — | |
| 10-Q | 2025-04-30 | 2025-03-31 | |
| 8-K | 2025-04-30 | — | |
| DEF 14A | 2025-04-11 | 2025-04-09 | |
| 8-K | 2025-03-24 | — | |
| 10-K | 2025-03-24 | 2024-12-31 | |
| 8-K | 2025-01-27 | 2025-01-22 | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-12-16 | — | |
| 8-K | 2024-11-18 | — | |
| 10-Q | 2024-10-30 | 2024-09-30 | |
| 8-K | 2024-10-30 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-06-10 | — | |
| 8-K | 2024-05-31 | 2024-05-29 | |
| 8-K | 2024-05-30 | — | |
| 8-K | 2024-05-20 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-29 | 2024-05-29 | |
| 10-K | 2024-03-14 | 2023-12-31 | |
| 8-K | 2024-03-14 | — | |
| 8-K | 2024-03-11 | — | |
| 8-K | 2024-02-16 | 2024-02-14 |
Showing 1–50 of 126 filings